Spine Journal - 2026-11-14 - Journal Article
Intervertebral disc versus vertebral body as the percutaneous sample site for pyogenic spondylodiscitis: Which yields a higher microbiological diagnosis? A prospective study.
Tang K, Li Y, He Y, Fan J, Yan G, Li Y, Wang H, Zhu Q, Lan T, Dong W
Topics
Key Takeaway
Percutaneous intervertebral disc biopsy yielded a 51.5% culture positivity rate versus 32.4% for vertebral body biopsy in pyogenic spondylodiscitis (P=0.002), supporting disc as the preferred sampling site.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This prospective single-center study compared simultaneous percutaneous disc and vertebral body biopsy culture yields in 68 patients with suspected pyogenic spondylodiscitis under C-arm guidance. Disc sampling was positive in 51.5% versus 32.4% for vertebral body (McNemar test, P=0.002). On GEE multivariable analysis, disc biopsy site, male sex, elevated ESR, procalcitonin, IL-6, and histopathologic acute inflammation were each independently associated with positive culture.
Key Limitation
The 15-month single-center enrollment produced a modest sample of 68 patients, and the study does not report antibiotic pre-treatment rates, which is a well-established confounder of culture positivity in spondylodiscitis.
Original Abstract
BACKGROUND CONTEXT
Pyogenic spondylodiscitis requires microbiological confirmation, yet percutaneous sample collection yield remains modest. The optimal sampling site in patients without drainable abscess is controversial. Retrospective studies suggest the disc may outperform the vertebral body, but evidence is limited by design biases, leaving the question unresolved.
PURPOSE
To determine whether the intervertebral disc or the vertebral body provides a better percutaneous biopsy site for microbiological diagnosis in patients with pyogenic spondylodiscitis.
STUDY DESIGN
Prospective cohort study conducted at a single spine center.
PATIENT SAMPLE
A total of 68 patients with high clinical suspicion of pyogenic spondylodiscitis who underwent C-arm guided percutaneous biopsy between January 2024 and April 2025.
OUTCOME MEASURES
Positive rate of bacterial culture (including aerobic and anaerobic) from biopsy specimens; factors associated with positive culture using generalized estimating equations (GEE).
METHODS
All enrolled patients underwent simultaneous percutaneous sample collections of both the vertebral body and the intervertebral disc under C-arm guidance. Specimens were sent for bacterial culture, anaerobic culture, metagenomic next-generation sequencing (mNGS), and histopathological examination. The McNemar test was used to compare paired culture positivity rates between the two sites. Multivariable analysis was performed using GEE to identify factors associated with positive cultures.
RESULTS
Of 279 screened patients with suspected spinal infections, 68 were included (39 males, 29 females; median age 64.0 years). The intervertebral disc yielded a significantly higher microbial identification rate than the vertebral body (35/68 [51.5%] vs. 22/68 [32.4%]; P=0.002). On multivariable analysis, factors significantly associated with positive cultures included male sex, elevated preoperative dynamic erythrocyte sedimentation rate (ESR), increased procalcitonin (PCT), elevated interleukin-6 (IL-6), histopathological evidence of acute inflammation, and biopsy site (all P<0.05). Notably, the intervertebral disc site remained independently associated with higher culture positivity.
CONCLUSIONS
In patients with pyogenic spondylodiscitis requiring solid-tissue sampling, percutaneous sampling of the intervertebral disc yields a significantly higher bacterial culture positivity rate than sampling of the vertebral body. Male sex, elevated ESR, PCT, IL-6, and acute inflammation on histopathology are also associated with positive cultures. These findings support prioritizing the intervertebral disc as the preferred percutaneous sampling target-reserving direct aspiration for accessible fluid collections-to optimize microbiological diagnosis in pyogenic spondylodiscitis.